10:00 am Characterizing Disease Progression Through Longitudinal Preclinical Studies to Inform Long-Term Clinical Strategies
Time: 10:00 am
day: Conf day 2
Details:
- Conducting longitudinal preclinical studies to more accurately understand MASH progression to lead to the development of long-term clinical strategies that effectively address the disease course
- Employing longitudinal preclinical models to enable the identification of key drivers and mechanisms of disease progression to facilitate the design of targeted interventions for personalized treatment approaches for MASH patients
- Leveraging insights from longitudinal preclinical data to allow for the development of predictive biomarkers and surrogate endpoints to monitor treatment response, optimize clinical trial design, and accelerate the development of effective therapies for MASH
